Oncobiologics, Inc. (OTLK) Reports Q4 Loss, Lags Revenue Estimates
Outlook TherapeuticsOutlook Therapeutics(US:OTLK) ZACKS·2025-12-19 23:31

Oncobiologics, Inc. (OTLK) came out with a quarterly loss of 0.22pershareversustheZacksConsensusEstimateofalossof0.22 per share versus the Zacks Consensus Estimate of a loss of 0.23. This compares to a loss of 0.77pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof+4.350.77 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +4.35%. A quarter ago, it was expected that this company would post a loss of 0.42 per share when it actually produced a loss of $0.44, delivering a surprise of -4.76%.Over the last four quarters, the company has su ...